Preoperative Radiation Therapy and Immediate Breast Reconstruction

The goal of this phase III randomized controlled trial (PRADAIIBE) is to assess if preoperative radiation therapy (Preop-RT) combined with immediate breast reconstruction (IBR) can safely improve both aesthetic and quality of life outcomes in breast cancer patients, compared to the standard of care (SoC) therapy consisting of post-mastectomy radiation therapy (PMRT) and delayed/immediate breast reconstruction, in a population of breast cancer patients with an indication of mastectomy and PMRT. The following hypotheses and outcomes will be assessed at the primary endpoint of 1 year of follow-u

Trial Details

NCT ID
NCT06739655
Phase
NA
Sponsor
Cancer Research Antwerp
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Preoperative radiotherapy
  • Postoperative radiotherapy
  • Immediate breast reconstruction
  • Immediate or delayed breast reconstruction
Locations (sample)
  • Edegem, Antwerpen, Belgium|51.15662,4.44504
  • Wilrijk, Antwerpen, Belgium|51.16734,4.39513
  • Brasschaat, Antwerp, Belgium|51.2912,4.49182
  • Namur, Namur, Belgium|50.4669,4.86746
  • Ghent, Oost Vlaanderen, Belgium|51.05,3.71667

Key Eligibility Criteria

  • In order to be eligible to participate in this study, a participant must meet all of the following criteria:
  • 1\. Women ≥18 years with histopathologically confirmed breast cancer who:
  • a. require SSM/NSM for any reason (e.g. extensive disease)
  • b. require postoperative radiation therapy of at least the chest wall

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →